Healthcare Sales & Marketing Network News: nasal drug delivery

Searching News Database: nasal drug delivery

HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel

HSMN NewsFeed - 24 Apr 2019
Satsuma Pharmaceuticals Raises $62 Million in Series B Preferred Stock Financing
Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA

HSMN NewsFeed - 5 Apr 2017
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 24

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 24 additional stories matching:
nasal drug delivery
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.